Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring

Vaccine
Claudia VellozziPenina Haber

Abstract

In preparation for pandemic vaccine safety monitoring, we assessed adverse events reported to the Vaccine Adverse Event Reporting System following receipt of trivalent inactivated influenza vaccines among adults from 1990 through 2005. We calculated reporting rates for nonserious, serious, and neurological adverse events. We reviewed reports of recurrent events and deaths, as well as reports identified through advanced signal detection. The most frequently reported events were local reactions and systemic symptoms. Guillain-Barré syndrome was the most frequently reported serious event (0.70 reports per million vaccinations). Adverse event reporting rates have been reasonably constant over time. No new safety concerns emerged after our review of 15 years of post-licensure surveillance data. These findings provide useful information if pandemic vaccine is rapidly distributed and pre-licensure data are limited.

References

Dec 1, 1977·The Journal of Infectious Diseases·C W BiermanJ P Fox
Aug 13, 1982·JAMA : the Journal of the American Medical Association·J E KaplanL B Schonberger
Dec 1, 1994·Clinical Rheumatology·D BiasiL M Bambara
Nov 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P BlancheD Sicard
May 1, 1994·Vaccine·R T ChenS G Wassilak
Dec 1, 1993·The American Journal of Psychiatry·N Boutros, B P Keck
May 29, 1998·The British Journal of Dermatology·A M DownsC T Kennedy
Sep 17, 1998·Archives of Internal Medicine·K L NicholT von Sternberg
Nov 18, 2000·Journal of the American Geriatrics Society·E LiozonG Gold
Apr 11, 2001·Archives of Internal Medicine·J FinstererS Redtenbacher
Jun 20, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ana SzarfmanRobert T O'Neill
Sep 19, 2002·Neurology·Transverse Myelitis Consortium Working Group
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W ScheifeleJudy MacDonald
Oct 3, 2003·Pediatrics·Kari BohlkeVaccine Safety Datalink Team
Apr 9, 2004·The Pediatric Infectious Disease Journal·Frederick VarricchioRobert T Chen
Jul 24, 2004·Journal of the American Geriatrics Society·Juan Marti, Enrique Anton
Nov 25, 2004·JAMA : the Journal of the American Medical Association·Penina HaberRobert T Chen
Jun 15, 2005·Pharmacoepidemiology and Drug Safety·David BanksRobert Ball
Aug 23, 2005·Journal of the American Academy of Dermatology·Steve A MayCandace Kasper
Mar 31, 2006·The New England Journal of Medicine·John J TreanorMark Wolff
Jun 28, 2006·Archives of Internal Medicine·Richard A HughesMartin C Gulliford
Feb 7, 2008·Expert Review of Vaccines·John Iskander, Karen Broder
Mar 14, 2008·Vaccine·Pengjun LuJames A Singleton

Citations

Jan 25, 2012·Obstetrics and Gynecology·Yao DingSylvia H Yeh
Sep 13, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Geneviève DurrieuFrench Network of Pharmacovigilance Centres
Mar 22, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·F ChavantM C Pérault-Pochat
Sep 2, 2011·Current Opinion in Pediatrics·David A Gruenberg, Marcus S Shaker
Sep 4, 2012·Current Infectious Disease Reports·Catherine J Derber, Shivanjali Shankaran
Feb 14, 2013·European Journal of Public Health·Lawrence D PhillipsThomas Lönngren
Apr 25, 2012·Der Nervenarzt·H-P HartungH C Lehmann
Nov 5, 2014·Expert Opinion on Drug Safety·Paul LoubetOdile Launay
Oct 7, 2015·Influenza and Other Respiratory Viruses·Leonoor Wijnans, Bettie Voordouw
Dec 22, 2011·Thérapie·Geneviève Durrieule réseau français des centres de pharmacovigilance
Dec 18, 2010·Neurología : publicación oficial de la Sociedad Española de Neurología·M E Marzo SolaÁ Gil Pujades
Mar 17, 2010·The Journal of Allergy and Clinical Immunology·John M Kelso
Dec 9, 2009·Advances in Pediatrics·Kam-Lun Hon, Alexander K C Leung
Jun 5, 2015·Human Vaccines & Immunotherapeutics·Luzhao FengHongjie Yu
Aug 10, 2010·The Australian Journal of Rural Health·Craig D FergusonWilliam J H McBride
Feb 4, 2012·Pediatrics International : Official Journal of the Japan Pediatric Society·Seung Jae LeeYoung Kuk Cho
Oct 1, 2011·Influenza and Other Respiratory Viruses·David J WangRobert G Webster
Oct 1, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Centers for Disease Control and Prevention
Jan 20, 2015·Influenza and Other Respiratory Viruses·Manilay PhengxayLao PDR Field Epidemiology Training Cohort Team
Oct 11, 2015·The Journal of Allergy and Clinical Immunology·Michael M McNeilFrank DeStefano
May 23, 2015·Vaccine·L H Martín AriasA Carvajal
May 26, 2015·Vaccine·Elaine R MillerTom T Shimabukuro
Jun 10, 2011·American Journal of Obstetrics and Gynecology·Evan R MyersGeeta K Swamy
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Paloma Carrillo-SantistevePier Luigi Lopalco
Sep 20, 2011·Vaccine·A Shoamanesh, A Traboulsee
Apr 20, 2011·Vaccine·Xavier KurzAna Hidalgo-Simon
Jul 18, 2012·PloS One·Gaston De SerresPHAC-CIHR influenza Research Network (PCIRN)
Aug 26, 2016·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Lisa A GrohskopfJoseph S Bresee
Sep 13, 2014·Journal of Health Services Research & Policy·Karen BornAndreas Laupacis
May 13, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Hélène BricoutTimothy David Caroe
Apr 14, 2012·Revista Do Instituto De Medicina Tropical De São Paulo·Eduardo Pernambuco de Souza, Marcelo de Souza Teixeira
Jun 26, 2014·Expert Review of Vaccines·John M Kelso
Jun 6, 2017·Journal of Korean Medical Science·Yong Shik ParkBum Chun Suh
Apr 2, 2020·Aging Medicine·Qiong ChenRecommendations for Influenza, Streptococcus pneumoniae Vaccination in Elderly People in China Writing Group, Geriatric Resp
Dec 21, 2019·BMC Pregnancy and Childbirth·Stéphanie BartoloKarine Faure
Dec 21, 2018·Revista Do Instituto De Medicina Tropical De São Paulo·Vera Lúcia GattásAlexander Roberto Precioso
Sep 6, 2020·Nature Reviews. Immunology·Mangalakumari JeyanathanZhou Xing
Nov 18, 2020·3 Biotech·N S Sampath KumarMahesh Kumar
Feb 4, 2021·Pharmacoepidemiology and Drug Safety·Chongliang LuoYong Chen
Mar 2, 2021·Journal of the American Medical Informatics Association : JAMIA·Jingcheng DuCui Tao
Mar 7, 2021·Virology·James Brett CaseMichael S Diamond

Related Concepts

Influenza
Trivalent Live Attenuated Influenza Vaccine
Adverse Drug Reaction Reporting Systems
Guillain-Barre Syndrome
Influenza virus vaccine
Vaccination
Vaccines
Infection Surveillance
Adverse Event

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.